F. Sala

发表

Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel proteasome inhibitor CEP-18770 in human plasma and its application in a clinical pharmacokinetic study.

M. Zucchetti, M. D’Incalci, R. Bagnati, 2010, Journal of mass spectrometry : JMS.

A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma.

M. Zucchetti, F. D. De Braud, G. Martinelli, 2013, European journal of cancer.

Development and validation of a high-performance liquid chromatography-tandem mass spectrometry method for the determination of the novel inhibitor of angiogenesis E-3810 in human plasma and its application in a clinical pharmacokinetic study.

M. Zucchetti, M. D’Incalci, R. Bagnati, 2011, Journal of mass spectrometry : JMS.

Characterization of a new trabectedin‐resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents

M. Rocchi, O. Capozzi, F. Grosso, 2012, International journal of cancer.

The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular).

C. Tiribelli, L. Rovati, N. Rosso, 2015, Current medicinal chemistry.

Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib

M. Zucchetti, P. Ubezio, M. D’Incalci, 2013, Cancer Chemotherapy and Pharmacology.

Development and validation of two liquid chromatography-tandem mass spectrometry methods for the determination of silibinin and silibinin hemisuccinate in human plasma.

L. Rovati, S. Persiani, M. Čolović, 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ST1926, a novel oral antitumor agent, adamantyl retinoid derivative, in plasma of patients in a Phase I study.

M. Zucchetti, M. D’Incalci, R. Bagnati, 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Silibinin hemisuccinate binding to proteins in plasma and blood cell/plasma partitioning in mouse, rat, dog and man in vitro

L. Rovati, Paola Vaghi, S. Persiani, 2013, Drug metabolism and drug interactions.

Evaluation of Levothyroxine Bioavailability after Oral Administration of a Fixed Combination of Soy Isoflavones in Post-menopausal Female Volunteers

C. Manzotti, L. Rovati, G. Giacovelli, 2015, Drug Research.

Pharmacokinetic profile of imatinib mesylate and N-desmethyl-imatinib (CGP 74588) in children with newly diagnosed Ph+ acute leukemias

M. Zucchetti, M. D’Incalci, A. Biondi, 2009, Cancer Chemotherapy and Pharmacology.

Simultaneous determination of gemcitabine and its main metabolite, dFdU, in plasma of patients with advanced non-small-cell lung cancer by high-performance liquid chromatography-tandem mass spectrometry.

M. Zucchetti, M. D’Incalci, E. Galligioni, 2008, Journal of mass spectrometry : JMS.

Pharmacokinetic study of gemcitabine, given as prolonged infusion at fixed dose rate, in combination with cisplatin in patients with advanced non-small-cell lung cancer

M. Zucchetti, E. Galligioni, E. Mini, 2010, Cancer Chemotherapy and Pharmacology.

Effect of a Combination of Berberine and Monacolin on CYP Enzymes : An Oral Cocktail Interaction Study in Healthy Volunteers

C. Manzotti, L. Rovati, G. Giacovelli, 2015 .